Submitted by Anonymous (not verified) on 30 July 2026 - 15:00
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation: 22/05/2014, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation: 22/05/2014, Revision: 16, Status: Authorised